2026 Biotimize. All rights reserved.

Biotimize

About Us

Biotimize About Us Graphics

Pioneering Biomanufacturing & Bioprocess Excellence in Latin America

Our Mission To accelerate biopharmaceutical development and manufacturing by making innovation accessible and economically viable, ensuring breakthrough therapies reach those who need them most.

Founded to bridge the gap between benchtop discovery and scalable industrial production, Biotimize stands out as Brazil's premier biopharmaceutical CDMO. We provide an integrated, end-to-end framework connecting cell engineering, process development, and non-clinical readiness to de-risk therapeutic pipelines for global partners.

Global Standards,
Local Sovereignty

By bolstering the regional Health Economic-Industrial Complex (CEIS), Biotimize drives self-reliance in complex biologics, replacing import dependence with local bioprocessing capability, technical sovereignty, and robust non-clinical development.

Optimizing Health

Biotimize’s Expertise

Cell Line & Bioprocess R&D

High-expression host cell engineering (mammalian & microbial), clone selection, and tailored upstream/downstream optimization for complex biopharmaceuticals.

End-to-End CDMO Platform

Seamless tech transfer from laboratory drug discovery and proof-of-concept to non-clinical batch production and pilot scale readiness (TRL 6).

Advanced Single-Use Infrastructure

State-of-the-art flexible bioreactors and analytical characterization tools aligned with ANVISA and ICH quality guidelines.

Scalable Growth Masterplan

Expanding infrastructure with a future-proof 20,000+ m² GMP production facility to support long-term commercial biomanufacturing needs.

Ecosystem

Democratizing drug development with Biotechnology as a Service.

Partner with Us to Accelerate Your Biomanufacturing Pipeline

Connect with our technical executives to evaluate your bioprocess roadmap, scale-up strategy, or non-clinical batch requirements.

Schedule a Consultation

LGPD

Rigorous company in relation to the general data protection law (LGPD)

Biotimize - Biotechnology as a Service is committed to complying with the laws that protect the privacy of the data of its employees, partners and the general public.
See how we deal with the information collected:

What are the data types? Personal data:
“Information relating to an identified or identifiable natural person”, for example: first name, last name, date of birth, personal documents, home or business address, telephone, email and IP address.

Sensitive Personal data:
These are the data that refer to racial or ethnic origin, religious conviction, political opinion, union affiliation or organization of a religious, philosophical or political nature. Sensitive personal data as well are those related to health or sex life, genetic or biometric data.

What data does our Company collect? Our company handles data from employees, partners and service providers, being duly compliant with the LGPD.
On the website, the company collects data through the voluntary and consensual completion of forms, e-books and contact to receive the newsletter.

Is there automatic data collection? Biotimize - Biotechnology as a Service does not automatically collect data in each access to the website.

How do they use my data? The personal data provided by users who fill in the forms are used solely to provide feedback at the user's request (individual or legal entity interested in our company's products and services).
Once the service is completed, such data is deleted.

Have you got any questions? Talk to the Data Protection Manager (DPO) by email: dpo@biotimize.com.br
You will be able to clarify doubts related to the processing of personal data.